vs
Envista Holdings Corp（NVST）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Envista Holdings Corp的季度营收约是Bio-Techne的2.5倍（$750.6M vs $295.9M）。Bio-Techne净利率更高（12.8% vs 4.4%，领先8.5%）。Envista Holdings Corp同比增速更快（15.0% vs -6.4%）。过去两年Envista Holdings Corp的营收复合增速更高（9.7% vs 4.2%）
Envista Holdings Corp是一家总部位于美国的企业，旗下Envista Forensics业务板块面向保险、法律及风险管理行业，在全球范围内提供法务工程与事故复原解决方案。公司前身为LWG咨询有限公司，2017年正式更名为Envista Forensics。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
NVST vs TECH — 直观对比
营收规模更大
NVST
是对方的2.5倍
$295.9M
营收增速更快
NVST
高出21.4%
-6.4%
净利率更高
TECH
高出8.5%
4.4%
两年增速更快
NVST
近两年复合增速
4.2%
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $750.6M | $295.9M |
| 净利润 | $32.9M | $38.0M |
| 毛利率 | 54.7% | 64.6% |
| 营业利润率 | 9.8% | 18.4% |
| 净利率 | 4.4% | 12.8% |
| 营收同比 | 15.0% | -6.4% |
| 净利润同比 | 2641.7% | 68.3% |
| 每股收益（稀释后） | $0.20 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVSTTECH
| Q4 25 | $750.6M | $295.9M | ||
| Q3 25 | $669.9M | — | ||
| Q2 25 | $682.1M | $317.0M | ||
| Q1 25 | $616.9M | $316.2M | ||
| Q4 24 | $652.9M | $297.0M | ||
| Q3 24 | $601.0M | $289.5M | ||
| Q2 24 | $633.1M | $306.1M | ||
| Q1 24 | $623.6M | $303.4M |
净利润NVSTTECH
| Q4 25 | $32.9M | $38.0M | ||
| Q3 25 | $-30.3M | — | ||
| Q2 25 | $26.4M | $-17.7M | ||
| Q1 25 | $18.0M | $22.6M | ||
| Q4 24 | $1.2M | $34.9M | ||
| Q3 24 | $8.2M | $33.6M | ||
| Q2 24 | $-1.2B | $40.6M | ||
| Q1 24 | $23.6M | $49.1M |
毛利率NVSTTECH
| Q4 25 | 54.7% | 64.6% | ||
| Q3 25 | 55.3% | — | ||
| Q2 25 | 54.2% | 62.7% | ||
| Q1 25 | 54.5% | 67.9% | ||
| Q4 24 | 57.1% | 65.3% | ||
| Q3 24 | 52.8% | 63.2% | ||
| Q2 24 | 51.6% | 66.4% | ||
| Q1 24 | 57.1% | 67.4% |
营业利润率NVSTTECH
| Q4 25 | 9.8% | 18.4% | ||
| Q3 25 | 8.6% | — | ||
| Q2 25 | 6.8% | -7.5% | ||
| Q1 25 | 6.3% | 12.2% | ||
| Q4 24 | 7.1% | 16.0% | ||
| Q3 24 | 3.5% | 13.8% | ||
| Q2 24 | -182.2% | 15.0% | ||
| Q1 24 | 7.7% | 22.1% |
净利率NVSTTECH
| Q4 25 | 4.4% | 12.8% | ||
| Q3 25 | -4.5% | — | ||
| Q2 25 | 3.9% | -5.6% | ||
| Q1 25 | 2.9% | 7.1% | ||
| Q4 24 | 0.2% | 11.7% | ||
| Q3 24 | 1.4% | 11.6% | ||
| Q2 24 | -181.9% | 13.3% | ||
| Q1 24 | 3.8% | 16.2% |
每股收益（稀释后）NVSTTECH
| Q4 25 | $0.20 | $0.24 | ||
| Q3 25 | $-0.18 | — | ||
| Q2 25 | $0.16 | $-0.11 | ||
| Q1 25 | $0.10 | $0.14 | ||
| Q4 24 | $0.00 | $0.22 | ||
| Q3 24 | $0.05 | $0.21 | ||
| Q2 24 | $-6.69 | $0.26 | ||
| Q1 24 | $0.14 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $172.9M |
| 总债务越低越好 | $1.4B | $260.0M |
| 股东权益账面价值 | $3.1B | $2.0B |
| 总资产 | $5.7B | $2.5B |
| 负债/权益比越低杠杆越低 | 0.47× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NVSTTECH
| Q4 25 | $1.2B | $172.9M | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | $162.2M | ||
| Q1 25 | $1.1B | $140.7M | ||
| Q4 24 | $1.1B | $177.5M | ||
| Q3 24 | $991.3M | $187.5M | ||
| Q2 24 | $1.0B | $152.9M | ||
| Q1 24 | $948.5M | $145.3M |
总债务NVSTTECH
| Q4 25 | $1.4B | $260.0M | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $346.0M | ||
| Q1 25 | $1.4B | $330.0M | ||
| Q4 24 | $1.4B | $300.0M | ||
| Q3 24 | $1.4B | $300.0M | ||
| Q2 24 | $1.5B | $319.0M | ||
| Q1 24 | $1.5B | $389.0M |
股东权益NVSTTECH
| Q4 25 | $3.1B | $2.0B | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $2.9B | $2.1B | ||
| Q3 24 | $3.1B | $2.1B | ||
| Q2 24 | $3.0B | $2.1B | ||
| Q1 24 | $4.1B | $2.0B |
总资产NVSTTECH
| Q4 25 | $5.7B | $2.5B | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $5.7B | $2.6B | ||
| Q1 25 | $5.5B | $2.6B | ||
| Q4 24 | $5.4B | $2.7B | ||
| Q3 24 | $5.5B | $2.7B | ||
| Q2 24 | $5.4B | $2.7B | ||
| Q1 24 | $6.6B | $2.7B |
负债/权益比NVSTTECH
| Q4 25 | 0.47× | 0.13× | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.46× | 0.18× | ||
| Q1 25 | 0.47× | 0.16× | ||
| Q4 24 | 0.48× | 0.14× | ||
| Q3 24 | 0.46× | 0.14× | ||
| Q2 24 | 0.51× | 0.15× | ||
| Q1 24 | 0.36× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | — |
| 自由现金流经营现金流 - 资本支出 | $91.7M | — |
| 自由现金流率自由现金流/营收 | 12.2% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | 3.28× | — |
| 过去12个月自由现金流最近4个季度 | $230.4M | — |
8季度趋势，按日历期对齐
经营现金流NVSTTECH
| Q4 25 | $108.0M | — | ||
| Q3 25 | $78.7M | — | ||
| Q2 25 | $88.7M | $98.2M | ||
| Q1 25 | $300.0K | $41.1M | ||
| Q4 24 | $132.4M | $84.3M | ||
| Q3 24 | $70.7M | $63.9M | ||
| Q2 24 | $93.1M | $75.5M | ||
| Q1 24 | $40.3M | $81.0M |
自由现金流NVSTTECH
| Q4 25 | $91.7M | — | ||
| Q3 25 | $67.9M | — | ||
| Q2 25 | $76.4M | $93.3M | ||
| Q1 25 | $-5.6M | $31.0M | ||
| Q4 24 | $123.8M | $77.5M | ||
| Q3 24 | $63.3M | $54.7M | ||
| Q2 24 | $86.3M | $57.5M | ||
| Q1 24 | $29.3M | $64.5M |
自由现金流率NVSTTECH
| Q4 25 | 12.2% | — | ||
| Q3 25 | 10.1% | — | ||
| Q2 25 | 11.2% | 29.4% | ||
| Q1 25 | -0.9% | 9.8% | ||
| Q4 24 | 19.0% | 26.1% | ||
| Q3 24 | 10.5% | 18.9% | ||
| Q2 24 | 13.6% | 18.8% | ||
| Q1 24 | 4.7% | 21.3% |
资本支出强度NVSTTECH
| Q4 25 | 2.2% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 1.8% | 1.5% | ||
| Q1 25 | 1.0% | 3.2% | ||
| Q4 24 | 1.3% | 2.3% | ||
| Q3 24 | 1.2% | 3.2% | ||
| Q2 24 | 1.1% | 5.9% | ||
| Q1 24 | 1.8% | 5.4% |
现金转化率NVSTTECH
| Q4 25 | 3.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.36× | — | ||
| Q1 25 | 0.02× | 1.82× | ||
| Q4 24 | 110.33× | 2.42× | ||
| Q3 24 | 8.62× | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | 1.71× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVST
| Other | $375.8M | 50% |
| Specialty Productsand Technologies | $188.4M | 25% |
| Equipmentand Consumables | $186.4M | 25% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
